Jason Sheltzer

4.7K posts

Jason Sheltzer banner
Jason Sheltzer

Jason Sheltzer

@JSheltzer

Assistant prof at @StanfordMed. Interested in aneuploidy, mitotic kinases, cancer therapeutics, and drug development. Co-founder x2.

Katılım Şubat 2016
1.9K Takip Edilen18.6K Takipçiler
Sabitlenmiş Tweet
Jason Sheltzer
Jason Sheltzer@JSheltzer·
Check out our new study in @ScienceMagazine, where we take on a 100-year-old debate: what’s the role of aneuploidy in cancer? We discovered that genetically removing extra chromosomes blocks cancer growth - a phenomenon we call “aneuploidy addiction”. science.org/doi/10.1126/sc…
English
48
334
1.2K
382.8K
Jason Sheltzer retweetledi
Alec Stapp
Alec Stapp@AlecStapp·
GLP-1 drugs are the ultimate validation of the techno-solutionist approach to society's most challenging problems. The obesity crisis seemed liked it would just get worse and worse forever. Scolding from public health officials didn't work. Proposals to completely overhaul our food systems were dead on arrival. Instead, we invented a weekly shot (based on Gila monster venom!) that fixes obesity directly. And now, thanks to the economic incentives in our biomedical industry, we have follow-on drugs that will be cheaper, even more effective, and easier to administer (by taking a pill instead of a shot). Policymakers should be focused on figuring out how we can get more breakthrough drugs like GLP-1s (and faster). They also should think hard about which slopulist ideas might inadvertently kill the goose that lays the golden eggs.
Alec Stapp tweet media
English
66
291
2.1K
192.5K
Jason Sheltzer retweetledi
Siyuan (Steven) Wang
Siyuan (Steven) Wang@SStevenWang·
Not sure how many people have noticed this: In the latest (Mar 4) release of 24 new research papers from Nature (top science journal), 8 came from the US and 8 came from China. nature.com/nature/researc… Among the 29 new research papers in Cell (top journal in biomedical sciences) released this year, 8 came from the US while 10 came from China. cell.com/cell/newarticl… Meanwhile US labs are suffering from the aftermath of the NIH/NSF funding disruptions - including drastically reduced funding rates and as a result diminishing lab sizes and competitiveness in #STEM research.
English
6
23
116
24.4K
Jason Sheltzer
Jason Sheltzer@JSheltzer·
We think that the chromosome engineering techniques that we’ve developed through this work will be broadly useful for creating isogenic models of other complex rearrangements associated with developmental syndromes. If you’re interested in collaborating, please get in touch!
English
0
0
1
376
Jason Sheltzer
Jason Sheltzer@JSheltzer·
This project was a fantastic collaboration with the Pinter Lab at UConn and the Davoli Lab at NYU. We’re grateful to @chromosome8p for supporting this work and for the individuals who provided the samples used in this analysis. genome.cshlp.org/content/36/3/5…
English
1
0
1
441
Jason Sheltzer
Jason Sheltzer@JSheltzer·
Thrilled to share my lab’s new paper out in @genomeresearch where we use chromosome engineering to deconstruct 8p syndrome - a rare developmental condition caused by inversions, duplications, and deletions on chromosome 8p.
Jason Sheltzer tweet media
English
3
19
91
8.1K
Jason Sheltzer
Jason Sheltzer@JSheltzer·
@ruth_hook_ two major unanswered questions IMO: (1) even if most aneuploid cells get expelled to the trophectoderm, does the embryo retain some degree of mosaicism? (2) is the degree of mosaic aneuploidy sufficient to result in problems with health or development?
English
0
0
2
732
Ruth Hook
Ruth Hook@ruth_hook_·
this paper came out almost five years ago and imo it should have been national news based on how many older couples are working with such a low n of embryos to begin with tl/dr: (~oversimplified, please read their work!) early aneuploidy is normal and development autocorrects
Ruth Hook tweet mediaRuth Hook tweet mediaRuth Hook tweet mediaRuth Hook tweet media
English
2
1
61
4.2K
Jason Sheltzer
Jason Sheltzer@JSheltzer·
My lab at @StanfordCancer is hiring a computational biologist to support our efforts studying alterations in tumor genomes. This is a great opportunity for individuals looking to gain additional research experience before applying to PhD programs. More info below - please share!
Jason Sheltzer tweet media
English
2
72
235
15.6K
richard white
richard white@whitefishlab·
@JSheltzer @ScienceMagazine This is crazy. Thanks for sharing this. Despite it all, twitter/x (whatever) is still a good way to disseminate science.
English
2
1
97
12.3K
Jason Sheltzer
Jason Sheltzer@JSheltzer·
AI is cool and all... but a new paper in @ScienceMagazine kind of figured out the origin of life? The paper reports the discovery of a simple 45-nucleotide RNA molecule that can perfectly copy itself.
Jason Sheltzer tweet media
English
181
1K
6.2K
862.3K
Jason Sheltzer
Jason Sheltzer@JSheltzer·
And Multivac said, "let there be GGC AGG GCA GCG CAG UCG GAC AUU GAU AAC GGA AUC GAG CCC GCC", and there was life!
English
12
53
717
40.2K
Jason Sheltzer
Jason Sheltzer@JSheltzer·
Let’s play a little game. Let’s say that you’re the CSO at a cancer pharma company, and you have to choose a target to go after. Here’s a gene – high expression is associated with poor prognosis in brain cancer. Looks like a good candidate for an inhibitor right?
Jason Sheltzer tweet media
English
67
1.4K
3.4K
0
Jason Sheltzer
Jason Sheltzer@JSheltzer·
@BenSiranosian can you give an example of a key bioinformatics decision where an LLM would provide the wrong answer?
English
1
0
1
78
Ben Siranosian, PhD
Ben Siranosian, PhD@BenSiranosian·
@JSheltzer I’m giving people an LLM-encouraged assignment. It should be quick with agentic coding but still requires key bioinformatics decisions. Also ask how they use ai in their workflow and what those decisions and justifications are.
English
1
0
1
82